(no subject)

From: I.L. Rodionov (rodionov@fibkh.serpukhov.su)
Date: Sun Feb 20 2000 - 02:10:09 EST


"Norman Watts" <WATTS@calvin.niams.nih.gov>
References: <01JM0I25KFAA9D4ICE@calvin.niams.nih.gov>
Subject: Re: MolBio, Mercury labeling at Cysteines
Date: Sun, 20 Feb 2000 07:10:15 +0300
Organization: Branch of IBCh
MIME-Version: 1.0
Content-Type: text/plain;
        charset="iso-8859-1"
Content-Transfer-Encoding: 7bit
X-Priority: 3
X-MSMail-Priority: Normal
X-Mailer: Microsoft Outlook Express 5.00.2314.1300
X-MimeOLE: Produced By Microsoft MimeOLE V5.00.2314.1300
To: Recipients of ABRF List <abrf@aecom.yu.edu>
Sender: Association of Biomolecular Resource Facilities <abrf-request@aecom.yu.edu>
Precedence: bulk
Errors-To: abrf-request@aecom.yu.edu

Dear Norman,

If the "engineered thiols" you are trying to label are thiols indeed
then you may not need to reduce them. But in case you deal with an
engineered disulfide bridge, then you'll get two thiol functions
spatially close to each other after DTT treatment . If so, it seems very
likely that a single Hg atom will bind both SH due to very strong
preference of bivalent mercury for sulfur ligands. As a consequence, the
apparent substitution will be close to 50% (1/2 Hg per SH).

DTT is believed to form the stable 6-membered disulfide exclusively.
The most impressive advantage of TCEP is its high efficiency in the
broad pH range (1.5-8.5).

Regards,

Igor Rodionov

Laboratory of Peptide Chemistry
Branch of Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry
6 Science Avenue, Pushchino, Moscow Region
142292, Russian Federation
rodionov@fibkh.serpukhov.su



This archive was generated by hypermail 2b29 : Thu Mar 16 2000 - 10:06:51 EST